Bergquist C

No ORCID on file · 6 papers in corpus · active 1989-2000

Study types

  • article 6

Condition tags

  • endometriosis 6
  • infertility 2
  • mesh:D004716 1
article 2000
Lakartidningen

The aim of pharmacological treatment of endometriosis is to reduce estrogen levels, which may be achieved using gestagens or GnRH-agonists. The effects of the different hormones are mainly the same, while side effects differ. If the GnRH-ag…

article 2000
Lakartidningen

Endometriosis is a common disease with serious consequences for the patient and for society. Until now there has been no reliable method for diagnosing endometriosis besides direct visualization, e.g. utilizing laparoscopy. IVF offers the m…

article 1997
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(97)70084-x

ObjectiveOur goal was to determine the effects of a repeated course of the gonadotropin-releasing hormone agonist nafarelin on symptoms and signs of endometriosis and lumbar and distal radius bone mineral density.Study designForty-five wome…

article 1991
Lakartidningen
article 1990
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(90)90438-d

This 6-month clinical trial with an additional 12-month follow-up compared the effects of treatment with the gonadotropin-releasing hormone agonist nafarelin and the androgenic agent danazol on lipids and calcium metabolism in women with en…

article 1989
The Journal of reproductive medicine

The preliminary results from an ongoing multicenter trial further support the efficacy and excellent tolerability of nafarelin in the management of endometriosis.